Published in J Biol Chem on March 11, 2004
Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev (2009) 2.53
The extended PP1 toolkit: designed to create specificity. Trends Biochem Sci (2010) 2.51
Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity. Mol Cell Biol (2007) 2.32
Targeting protein serine/threonine phosphatases for drug development. Mol Pharmacol (2009) 1.25
Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. Eur J Neurosci (2005) 1.20
Selective targeting of the gamma1 isoform of protein phosphatase 1 to F-actin in intact cells requires multiple domains in spinophilin and neurabin. FASEB J (2008) 0.92
Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a Parkinson disease model. J Biol Chem (2008) 0.89
Identification and validation of novel spinophilin-associated proteins in rodent striatum using an enhanced ex vivo shotgun proteomics approach. Mol Cell Proteomics (2010) 0.87
Differential localization of protein phosphatase-1alpha, beta and gamma1 isoforms in primate prefrontal cortex. Cereb Cortex (2005) 0.86
Age-dependent targeting of protein phosphatase 1 to Ca2+/calmodulin-dependent protein kinase II by spinophilin in mouse striatum. PLoS One (2012) 0.86
Wip1 phosphatase positively modulates dendritic spine morphology and memory processes through the p38MAPK signaling pathway. Cell Adh Migr (2012) 0.83
Differential regulation of protein phosphatase-1(I) by neurabin. Biochem Biophys Res Commun (2007) 0.75
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell (2008) 6.16
Calmodulin kinase II inhibition protects against structural heart disease. Nat Med (2005) 5.87
PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med (2004) 4.50
Concern Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation (2002) 4.16
Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res (2005) 2.52
Retracted L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII. Mol Cell (2006) 2.49
Phosphate incorporation during glycogen synthesis and Lafora disease. Cell Metab (2011) 2.03
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron (2006) 2.00
Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci (2010) 1.99
Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol (2002) 1.97
Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem (2002) 1.90
Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Circulation (2006) 1.85
Structural basis for regulation of protein phosphatase 1 by inhibitor-2. J Biol Chem (2007) 1.74
Calmodulin kinase II activity is required for normal atrioventricular nodal conduction. Heart Rhythm (2005) 1.63
Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2. J Biol Chem (2005) 1.46
CaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations. Proc Natl Acad Sci U S A (2010) 1.42
Alcohol exposure alters NMDAR function in the bed nucleus of the stria terminalis. Neuropsychopharmacology (2009) 1.41
Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol Pharmacol (2008) 1.38
PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet (2011) 1.35
Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol Dis (2010) 1.33
Exercise capacity of mice genetically lacking muscle glycogen synthase: in mice, muscle glycogen is not essential for exercise. J Biol Chem (2005) 1.31
A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II. J Neurosci (2003) 1.31
Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: the neurabin I/PP1 complex regulates cell morphology. Mol Cell Biol (2002) 1.29
Differential modulation of Ca2+/calmodulin-dependent protein kinase II activity by regulated interactions with N-methyl-D-aspartate receptor NR2B subunits and alpha-actinin. J Biol Chem (2005) 1.28
Abnormal cardiac development in the absence of heart glycogen. Mol Cell Biol (2004) 1.28
GluN2B subunit deletion reveals key role in acute and chronic ethanol sensitivity of glutamate synapses in bed nucleus of the stria terminalis. Proc Natl Acad Sci U S A (2012) 1.21
Structural basis for glucose-6-phosphate activation of glycogen synthase. Proc Natl Acad Sci U S A (2010) 1.21
Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism. J Biol Chem (2010) 1.20
Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. Eur J Neurosci (2005) 1.20
Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci (2010) 1.19
Retracted Cytoskeletal disrupting agents prevent calmodulin kinase, IQ domain and voltage-dependent facilitation of L-type Ca2+ channels. J Physiol (2002) 1.16
Glucose metabolism in mice lacking muscle glycogen synthase. Diabetes (2005) 1.15
Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein. Protein Expr Purif (2003) 1.13
Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism. Parkinsonism Relat Disord (2007) 1.12
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nat Neurosci (2013) 1.11
CaMKIIalpha enhances the desensitization of NR2B-containing NMDA receptors by an autophosphorylation-dependent mechanism. Mol Cell Neurosci (2005) 1.11
Differential regulated interactions of calcium/calmodulin-dependent protein kinase II with isoforms of voltage-gated calcium channel beta subunits. Biochemistry (2008) 1.08
Ca2+-dependent facilitation of Cav1.3 Ca2+ channels by densin and Ca2+/calmodulin-dependent protein kinase II. J Neurosci (2010) 1.08
CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction. J Mol Med (Berl) (2006) 1.08
Retracted C terminus L-type Ca2+ channel calmodulin-binding domains are 'auto-agonist' ligands in rabbit ventricular myocytes. J Physiol (2003) 1.07
The neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunits. J Biol Chem (2002) 1.07
Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulin-dependent protein kinase II. J Clin Invest (2006) 1.05
Retracted A dynamic alpha-beta inter-subunit agonist signaling complex is a novel feedback mechanism for regulating L-type Ca2+ channel opening. FASEB J (2005) 1.04
Phosphorylation of TPX2 by Plx1 enhances activation of Aurora A. Cell Cycle (2009) 1.03
Spinophilin stabilizes cell surface expression of alpha 2B-adrenergic receptors. J Biol Chem (2003) 1.03
Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2. Cardiovasc Res (2005) 1.03
Glycogen metabolism in tissues from a mouse model of Lafora disease. Arch Biochem Biophys (2006) 1.00
Transparency Is the Key to Quality. J Biol Chem (2015) 0.99
Suppression of dynamic Ca(2+) transient responses to pacing in ventricular myocytes from mice with genetic calmodulin kinase II inhibition. J Mol Cell Cardiol (2006) 0.98
Substrate-selective and calcium-independent activation of CaMKII by α-actinin. J Biol Chem (2012) 0.97
Relationship between glycogen accumulation and the laforin dual specificity phosphatase. Biochem Biophys Res Commun (2006) 0.97
Calmodulin kinase is functionally targeted to the action potential plateau for regulation of L-type Ca2+ current in rabbit cardiomyocytes. J Physiol (2004) 0.94
Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice. Mol Cell Neurosci (2011) 0.93
Developmentally regulated alternative splicing of densin modulates protein-protein interaction and subcellular localization. J Neurochem (2008) 0.93
Characterization of a central Ca2+/calmodulin-dependent protein kinase IIalpha/beta binding domain in densin that selectively modulates glutamate receptor subunit phosphorylation. J Biol Chem (2011) 0.92
Selective targeting of the gamma1 isoform of protein phosphatase 1 to F-actin in intact cells requires multiple domains in spinophilin and neurabin. FASEB J (2008) 0.92
Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability. PLoS One (2012) 0.91
CaMKII associates with CaV1.2 L-type calcium channels via selected beta subunits to enhance regulatory phosphorylation. J Neurochem (2009) 0.91
A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice. PLoS Med (2008) 0.91
Conformational changes underlying calcium/calmodulin-dependent protein kinase II activation. EMBO J (2011) 0.90
Oxidation of calmodulin alters activation and regulation of CaMKII. Biochem Biophys Res Commun (2007) 0.90
Sociodemographic and Psychological Correlates of Sun Protection Behaviors among Outdoor Workers: A Review. J Skin Cancer (2013) 0.89
Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a Parkinson disease model. J Biol Chem (2008) 0.89
Inhibition of pancreatic β-cell Ca2+/calmodulin-dependent protein kinase II reduces glucose-stimulated calcium influx and insulin secretion, impairing glucose tolerance. J Biol Chem (2014) 0.88
Time-dependent activation of Phox2a by the cyclic AMP pathway modulates onset and duration of p27Kip1 transcription. Mol Cell Biol (2009) 0.88
Identification and validation of novel spinophilin-associated proteins in rodent striatum using an enhanced ex vivo shotgun proteomics approach. Mol Cell Proteomics (2010) 0.87
Determination of mammalian glycogen synthase phosphatase activity. Methods Enzymol (2003) 0.86
Age-dependent targeting of protein phosphatase 1 to Ca2+/calmodulin-dependent protein kinase II by spinophilin in mouse striatum. PLoS One (2012) 0.86
CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling. Nat Neurosci (2013) 0.86
Differential localization of protein phosphatase-1alpha, beta and gamma1 isoforms in primate prefrontal cortex. Cereb Cortex (2005) 0.86
Multiple glycogen-binding sites in eukaryotic glycogen synthase are required for high catalytic efficiency toward glycogen. J Biol Chem (2011) 0.86
Differential association of postsynaptic signaling protein complexes in striatum and hippocampus. J Neurochem (2012) 0.84
Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. Am J Physiol Heart Circ Physiol (2008) 0.84
Basis for MAP4 dephosphorylation-related microtubule network densification in pressure overload cardiac hypertrophy. J Biol Chem (2010) 0.84
Reversal of diet-induced glucose intolerance by hepatic expression of a variant glycogen-targeting subunit of protein phosphatase-1. J Biol Chem (2001) 0.83
Analysis of specific interactions of native protein phosphatase 1 isoforms with targeting subunits. Methods Enzymol (2003) 0.83
Metabolic activation of CaMKII by coenzyme A. Mol Cell (2013) 0.82
Osteoporosis knowledge and attitudes: a cross-sectional study among college-age students. J Am Coll Health (2007) 0.82
A potassium channel blocker induces a long-lasting enhancement of corticostriatal responses. Neuropharmacology (2005) 0.81
Protein degradation and quality control in cells from laforin and malin knockout mice. J Biol Chem (2014) 0.81
Skin cancer preventative behaviors in state park workers: a pilot study. Environ Health Prev Med (2014) 0.80
Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinase. BMC Neurosci (2003) 0.80
Metabolic regulation of CaMKII protein and caspases in Xenopus laevis egg extracts. J Biol Chem (2013) 0.80
Quantitative proteomics analysis of CaMKII phosphorylation and the CaMKII interactome in the mouse forebrain. ACS Chem Neurosci (2015) 0.80
Localization of myocyte enhancer factor 2 in the rodent forebrain: regionally-specific cytoplasmic expression of MEF2A. Brain Res (2009) 0.80
Past and recent physical activity and bone mineral density in college-aged women. J Strength Cond Res (2004) 0.79
Skin Cancer Knowledge, Beliefs, Self-Efficacy, and Preventative Behaviors among North Mississippi Landscapers. Dermatol Res Pract (2013) 0.79
Sun-related behaviors among individuals previously diagnosed with non-melanoma skin cancer. Indian J Dermatol Venereol Leprol (2015) 0.77
Influence of yard work and weight training on bone mineral density among older U.S. women. J Women Aging (2002) 0.77
Calmodulin kinase II inhibition disrupts cardiomyopathic effects of enhanced green fluorescent protein. J Mol Cell Cardiol (2007) 0.76